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ARTICLE
Structure and regulation of ZCCHC4 in m6A-
methylation of 28S rRNA
Wendan Ren 1,5, Jiuwei Lu 1,5, Mengjiang Huang1, Linfeng Gao 2, Dongxu Li3,4,
Gang Greg Wang 3,4 & Jikui Song 1,2*
N6-methyladenosine (m6A) modification provides an important epitranscriptomic mechan-
ism that critically regulates RNA metabolism and function. However, how m6A writers attain
substrate specificities remains unclear. We report the 3.1 Å-resolution crystal structure of
human CCHC zinc finger-containing protein ZCCHC4, a 28S rRNA-specific m6A methyl-
transferase, bound to S-adenosyl-L-homocysteine. The methyltransferase (MTase) domain of
ZCCHC4 is packed against N-terminal GRF-type and C2H2 zinc finger domains and a C-
terminal CCHC domain, creating an integrated RNA-binding surface. Strikingly, the MTase
domain adopts an autoinhibitory conformation, with a self-occluded catalytic site and a fully-
closed cofactor pocket. Mutational and enzymatic analyses further substantiate the mole-
cular basis for ZCCHC4-RNA recognition and a role of the stem-loop structure within sub-
strate in governing the substrate specificity. Overall, this study unveils unique structural and
enzymatic characteristics of ZCCHC4, distinctive from what was seen with the METTL family
of m6A writers, providing the mechanistic basis for ZCCHC4 modulation of m6A RNA
methylation.
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Covalent modifications of RNA molecules represent anevolutionarily conserved epitranscriptomic mechanismthat critically regulates diverse cellular activities1. One of
the most prevalent RNA modifications is N6-methyladenosine
(m6A), which is widely present in mRNA and long noncoding
RNA (lncRNA)2, as well as in the ribosomal RNA (rRNA)3,4 and
small nuclear RNA (snRNA)5,6. Specific methylation of these
RNA molecules functions to modulate RNA structure and
protein–RNA interactions, which in turn influences RNA meta-
bolism, cell signaling, cell survival, and differentiation7,8. Dysre-
gulation of m6A-based RNA modification has been associated
with severe human diseases, such as cancer9,10.
The dynamic profiling of m6A across the epitranscriptome is
mediated by an array of distinct writer enzymes. For instance,
mRNA and lncRNA are primarily methylated by the
METTL3–METTL14 heterodimeric complex11–15, which recognizes
a DRACH (D: A, G, U; R: G, A; H: A, C, U) consensus sequence
near 3′ UTR16–18, whereas a subset of mRNA and snRNA sites is
distinctly methylated by RNA methyltransferase METTL1619, which
recognizes a UACAGAGAA motif embedded in a stem-loop
structure20,21. In addition, m6A modification of cap adenosine at
the transcription start nucleotide of mRNAs is achieved by cap-
specific methyltransferase CAPAM, which then promotes translation
of capped mRNAs22. Recent studies have further demonstrated that
the m6A modification on the site 4220 of 28S rRNA and site 1832 of
18S rRNA is, respectively, mediated by CCHC zinc finger-containing
protein ZCCHC4 and the methyltransferase METTL59,23. Notably,
these identified RNA methyltransferases bear no sequence homol-
ogy, except for a remotely related methyltransferase (MTase) domain
(Supplementary Fig. 1), raising a question of the molecular basis
underlying their distinct substrate specificities.
ZCCHC4 is a newly identified m6A RNA methyltransferase
and is highly conserved in multicellular organisms9,23. ZCCHC4
knockout in human cells eliminates the m6A4220 methylation of
28S rRNA9,23, but not any other identified m6A sites23, suggesting
its exclusive role in methylating 28S rRNA. ZCCHC4-mediated
m6A4220 methylation in 28S rRNA promotes ribosome assembly
and translation, which in turn impacts cell proliferation and
tumor growth9. In addition, a previous study on K-Ras-
transformed cells has identified ZCCHC4 as a potential factor
required for Ras-mediated gene silencing24. However, due to the
lack of structural information, the mechanism by which ZCCHC4
recognizes and methylates its RNA substrate remains unknown.
To provide mechanistic insights into the ZCCHC4-mediated
m6A RNA methylation, we determined the crystal structure of
human ZCCHC4 at 3.1 Å resolution. Distinct from what was
observed for all other m6A methyltransferases, ZCCHC4 is
organized into four domains, with three flanking zinc finger
domains packed around the MTase domain, forming an inte-
grated RNA-binding platform. Strikingly, the catalytic center is
blocked by a linker sequence, namely regulatory loop, bridging
the MTase domain and the C-terminal CCHC domain, resulting
in an autoinhibitory conformation. Furthermore, the SAM-
binding pocket adopts a fully closed conformation, suggesting
of a mechanism by which cofactor binding is coupled with RNA
substrate recognition. In addition, mutational and enzymatic
analyses reveal a role of the stem-loop structure within the RNA
substrate in governing the substrate specificity. Together, this
work reveals the previously unappreciated molecular mechanisms
that underlie activity autoregulation and substrate binding of
ZCCHC4 in the modulation of cellular m6A RNA methylation.
Results
Overall structure of the ZCCHC4–SAH complex. ZCCHC4
predictably contains a MTase domain with a DPPF catalytic
motif, flanked by an N-terminal GRF (Gly–Arg–Phe)-type zinc
finger domain and a C-terminal CCHC domain9 (Fig. 1a). Based
on sequence conservation analysis (Supplementary Fig. 2a), we
identified an evolutionarily conserved core fragment of human
ZCCHC4 (residues 24–464; ZCCHC424-464) (Fig. 1a, b), encom-
passing all the predicted domains. For successful crystallization,
we further mutated five putative surface residues of ZCCHC424-
464 each into alanine (see the Methods section), which permitted
crystallization and structure determination. The crystal structure
of ZCCHC424-464, in complex with S-adenosyl-L-homocysteine
(SAH), product of methyl donor S-adenosyl-L-methionine
(SAM), was refined to 3.1 Å resolution (Fig. 1b; Supplementary
Table 1). There are six ZCCHC424-464 complexes in one asym-
metric unit; among these, two ZCCHC4 molecules engage
swapping of the N-terminal tail (residues M26-V28) of one to
pair in antiparallel with residues F48-V51 of the other (Supple-
mentary Fig. 2b), likely due to crystal packing effects. These two
molecules also yield the highest-quality electron density map,
with one of which permitting the modeling of the entire segment
of residues M25-G440. We therefore chose this ZCCHC4 mole-
cule for structural analysis. The N-terminal regions of all the
other ZCCHC4 molecules are not involved in domain swapping,
in line with the fact that ZCCHC4 exists as a monomer in
solution, as demonstrated by our size-exclusion chromatography
analysis (Supplementary Fig. 2c).
The structure of ZCCHC424-464 reveals four closely packed
domains: an N-terminal GRF zinc finger domain is followed by a
C2H2 zinc finger domain, an MTase domain, and a C-terminal
CCHC zinc finger domain, folded into an integrated structural
unit (Fig. 1b). The MTase domain is comprised of seven-stranded
β-sheet, formed by five parallel strands and two antiparallel
capping strands (Fig. 1b, c). This central β-sheet is further flanked
by three intervening α-helices on each side (Fig. 1b). The SAH
molecule snugly fits into a fully closed pocket, lined by a loop
connecting the C2H2 domain and the MTase domain (cofactor
loop: residues P163-F175), the terminal ends of αG-helix and β8-
strand, and the DPPF (D276-P277-P278-F279) catalytic motif
(Fig. 1d; Supplementary Fig. 3). The homocysteine moiety of SAH
is surrounded by the side chains of L174-F175, T200-R202, and
D276, with the amino group donating a hydrogen bond to the
side-chain carboxylate of D276 and the carboxylate receiving a
hydrogen bond from the backbone amide of F175 (Fig. 1d). On
the other end, the adenosyl moiety of SAH is embraced by the
side chains of I226, N243, M244, and F245 through van der
Waals contacts, with the N6 atom further forming a hydrogen
bond with the side-chain carbonyl group of N243 (Fig. 1d). In
addition, the sugar moiety of SAH is recognized by Q172 and
D225 through hydrogen-bonding interactions (Fig. 1d). It is
worth noting that this closure of SAH-binding pocket is similar to
that of CAPAM (Supplementary Fig. 4a, b), but distinct from
those of METTL3, METTL5, and METTL16, in which the
cofactor-binding pockets are rather exposed to the solvent
(Supplementary Fig. 4c–e). In fact, the residues involved in the
cofactor binding are poorly conserved among these m6A RNA
methyltransferases (Supplementary Figs. 1, 4), highlighting their
divergent cofactor-binding mechanisms.
The tandem GRF and C2H2 domains flank one end of the
central β-sheet, with the GRF domain stacking on top of the
SAH-binding pocket and the C2H2 domain docked in the groove
formed by helices αG and αH of the MTase domain (Fig. 1b;
Supplementary Fig. 5a). The structure of the GRF zinc finger
domain is dominated by a three-stranded antiparallel β-sheet,
with a CHCC zinc cluster embedded between the loop preceding
β1 and the linker connecting β2 and β3 (Fig. 1b; Supplementary
Fig. 5a, b). In addition, the three-stranded β-sheet of GRF is
appended by a C-terminal α-helix that guides the packing of the
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GRF domain toward the MTase domain (Fig. 1b; Supplementary
Fig. 5a). The C2H2 zinc finger domain adopts an α/β-fold
arranged in an α-β-β-α-β-α-α fashion, with a C2H2 zinc cluster
formed between the loop connecting β4 and β5 and the loop
connecting β6 and αD (Fig. 1b; Supplementary Fig. 5a, c).
Association of the GRF and C2H2 domains with the MTase
domain is both mediated by surface complementarity, which
permits formation of extensive interdomain van der Waals and
hydrogen-bonding contacts centered around the SAH-binding
pocket (Supplementary Fig. 5a). The opposite end of the central
β-sheet is sided by the CCHC domain, comprised of four
consecutive two-stranded β-sheets and a C-terminal tail, stacking
on top of each other to form four CCHC zinc clusters in a spacing
of 10–11 Å (Fig. 1b; Supplementary Fig. 5a, d). Association of the
CCHC domain with the MTase domain is mainly mediated by
hydrogen bonds formed between residues from the start strands
of the CCHC domain and the C-terminal end of the MTase
domain (Supplementary Fig. 5a). As a result of these domain
arrangements, the GRF and CCHC domains both position one
end to flank the catalytic site of the MTase domain, while
extending the other end away from the MTase domain, each
adopting a claw-like conformation roofing the catalytic site
(Fig. 1b).
Structural homology search using the Dali server25 reveals that
the GRF domain of ZCCHC4 is well aligned with the
corresponding domain of APE2 (apurinic/apyrimidinic endonu-
clease 2) nuclease26 (Supplementary Fig. 5e); among the most
conserved sites are those involved in the interactions of APE2
with single-stranded DNAs for 3′–5′ exonuclease processing26.
The CCHC domain of ZCCHC4 bears a remote homology with
the CCHC motif of the DHHC (Asp–His–His–Cys) palmitoyl-
transferases (Supplementary Fig. 5f), which harbors a catalytic
center for protein palmitoylation27. On the other hand, there is
no structural homologue identified for the C2H2 domain.
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Fig. 1 Crystal structure of ZCCHC4. a Domain architecture of ZCCHC4, with individual domains indicated by residue numbers. b Ribbon representation of
ZCCHC424-464 bound to SAH, with the β-strands and α-helices numbered numerically and alphabetically, respectively. The zinc ions are shown as purple
spheres. c Schematic representation of the structure of ZCCHC4. The zinc ions are represented by purple spheres. The catalytic site is marked with red
star. d Close-up view of the interaction between ZCCHC4 (cyan) and SAH (yellow), with hydrogen-bonding interactions depicted as dashed lines and the
Fo–Fc omit map (magenta) of SAH contoured at 3σ level. e Methylation activity of full-length (FL), core (ZCCHC424-464) or domain-truncated ZCCHC4.
The data are mean ± SD. Statistical analysis used two-tailed Student’s t test for the difference from FL: ***p < 0.001. n.s., not significant. Source data are
provided as a Source Data file
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The MTase-flanking domains are required for ZCCHC4
activity. The close association between MTase and the flanking
domains potentially creates an extended RNA-binding surface,
implying a possible contribution of the flanking domains to the
RNA binding of ZCCHC4 (Fig. 1b). To test the role of the
MTase-flanking domains in ZCCHC4-mediated RNA methyla-
tion, we have measured the methylation activity of ZCCHC4,
either intact or domain-truncated, on a 30-mer RNA substrate,
derived from the Ade4220-containing segment of 28S rRNA
(Cyt4199-Gua4228) (Fig. 1e). As expected, the ZCCHC424-464 core
fragment shows a comparable activity with full-length ZCCHC4.
In contrast, deletion of the C-terminal CCHC domain (ΔCCHC)
led to a dramatic reduction of enzymatic activity, while deletion of
the N-terminal GRF domain, either alone (ΔGRF) or together with
the C2H2 domain (ΔGRF-C2H2), completely abolished the
activity of ZCCHC4, indicating the critical requirement of these
domains for ZCCHC4-mediated RNA methylation. Consistently,
electrophoretic mobility shift assays (EMSA) revealed that, in
comparison with wild-type ZCCHC424-464, the ΔGRF, ΔGRF-
C2H2, and ΔCCHC truncations all substantially impair the RNA-
binding affinity of ZCCHC4 (Supplementary Fig. 5 g). Analysis of
1D 1H NMR spectra of these domain-truncated ZCCHC4 frag-
ments indicate that they remain folded in solution (Supplemen-
tary Fig. 6), supporting a direct role of the flanking domains in
mediating substrate binding of ZCCHC4.
ZCCHC4 MTase domain adopts an autoinhibitory conforma-
tion. The MTase domain of ZCCHC4 merely shares ~6–17%
sequence identity with the corresponding domains of all other
m6A RNA methyltransferases identified so far (Supplementary
Fig. 1). Nevertheless, their structures exhibit a similar Rossmann
fold, with the catalytic motif aligned next to the SAH-binding
pocket (Fig. 2a–c; Supplementary Fig. 7a–d), suggestive of a
conserved catalytic mechanism. Astonishingly, structural com-
parison of ZCCHC4 with METTL16, as well as other RNA
methyltransferases, also reveals a striking difference in the active-
site conformation: the D/N-P-P-F/W catalytic motifs of
METTL16, METTL3, METTL5, and CAPAM are all readily
accessible for RNA contacts (Fig. 2b; Supplementary Fig. 7a–d);
in contrast, the corresponding DPPF motif in ZCCHC4 is shiel-
ded from solvent exposure by the loop connecting αK and β13
(hereafter referred to as regulatory loop), which wedges into the
catalytic center for interaction with the active-site residues
(Fig. 2a, c). Of particular note, residue D276 forms a bifurcated
side-chain hydrogen bond with regulatory loop residue Y340
(Fig. 2c), which potentially occludes D276 from nucleophilic
attack during the methylation reaction. Furthermore, the aro-
matic ring of residue F279, which presumably aligns the target
base during the methylation reaction (Fig. 2b), stacks against the
aliphatic chain of regulatory loop residue L345 (Fig. 2c). In
addition, regulatory loop residue D341 reaches over to form a salt
bridge with R202 on the SAH-binding pocket, which further
supports the positioning of the regulatory loop to the active site.
These observations suggest that ZCCHC4 adopts an auto-
inhibitory conformation.
To test the effect of the intramolecular interactions observed
above on the methylation activity of ZCCHC4, we have selected
the active site-contacting residues, including Y340, D341, and
L345, of the regulatory loop for mutagenesis and enzymatic assay.
In comparison with wild-type ZCCHC4, mutation of residues
D341 and L345 each into alanine led to a 1.3- and 2.2-fold
increase in RNA methylation (Fig. 2d), supporting the idea that
the intramolecular interaction between the regulatory loop and
the catalytic motif results in enzymatic inhibition of ZCCHC4.
On the other hand, introduction of the Y340A mutation severely
impairs the methylation activity of ZCCHC4, suggesting that
residue Y340 might also play an additional role in the enzymatic
catalysis. Indeed, structural alignment of ZCCHC4 and the RNA-
bound METTL16 reveals that in METTL16, the segment that
corresponds to the regulatory loop engages extensive contacts
with the RNA loop (Fig. 2a, b), implying a similar role of the
regulatory loop of ZCCHC4 in substrate recognition, and a
conformational readjustment of the regulatory loop accompany-
ing this process. Together, these data suggest that ZCCHC4
adopts an autoinhibitory conformation that may regulate its RNA
substrate specificity.
Regulation of ZCCHC4 on SAM binding and RNA methyla-
tion. Structural analysis of ZCCHC4 further reveals an interac-
tion between the regulatory loop and the cofactor loop (Fig. 2e):
residues N342 and H343 from the regulatory loop interact with
residues L174 and Y173 on the cofactor loop through hydrogen-
bonding and ring-stacking interactions, respectively (Fig. 2e).
These interactions presumably stabilize the closed conformation
of the SAM-binding pocket in the RNA-free state of ZCCHC4,
therefore implying a role of the regulatory loop in controlling the
cofactor binding of ZCCHC4. To test this possibility, we mea-
sured the SAM-binding affinities of wild-type and H343A-
mutated ZCCHC4 by Isothermal Titration Calorimetry (ITC).
Wild-type ZCCHC binds to SAM with a dissociation constant
(Kd) of 6.7 μM (Fig. 2f; Supplementary Fig. 7e), consistent with
the extensive interactions between ZCCHC4 and SAH (Fig. 1c).
In contrast, titration of the H343A mutant with SAM gave a Kd of
1.6 μM (Fig. 2f; Supplementary Fig. 7f), ~four fold stronger than
the binding between wild-type ZCCHC4 and SAM, indicating
that disruption of the intramolecular interaction between the
regulatory loop and cofactor loop significantly increases the
SAM-binding affinity of ZCCHC4.
To explore the role of the cofactor loop in the ZCCHC4-
mediated RNA methylation, we modeled the target adenosine
into the active site of ZCCHC4 based on structural alignment of
the ZCCHC4 MTase domain and HP1 RNA-bound METTL16
(PDB 6DU4)20 (Supplementary Fig. 7g). The structural model
indicates that the cofactor loop is in close proximity to the RNA
substrate, with loop residue Y173 flanking the adenosine ring in a
fashion similar to that of residues L75 and I218 of METTL16
(Fig. 2b; Supplementary Fig. 7g). Consistently, mutation of
cofactor loop residue Y173 into alanine largely abolishes the
methylation activity of ZCCHC4 (Fig. 2g). Likewise, mutations of
the regulatory loop residues N342 and H343 each into alanine
also severely impair the activity of ZCCHC4 (Fig. 2g), reinforcing
the notion that the regulatory loop is engaged in the ZCCHC4-
mediated methylation. Note that EMSA assays indicated that the
mutations on the regulatory loop do not significantly affect the
RNA-binding activity of ZCCHC4 (Supplementary Fig. 8a),
suggesting a role of these residues in enzymatic catalysis, rather
than substrate binding of ZCCHC4. Together, these studies
suggest that the intramolecular interaction between the regulatory
loop and the cofactor loop might not only restrict the SAM-
binding activity of ZCCHC4 but also strengthen the autoinhibi-
tory regulation mediated by the regulatory loop, thereby
establishing a link between the RNA recognition of ZCCHC4
and its SAM-binding activity.
Sequence- and structure-recognition of 28S rRNA by
ZCCHC4. Previous studies have indicated that ZCCHC4, with
substrate preference toward the AAC RNA motif in vitro, is
highly specific toward Ade4220 of 28S rRNA9,23, located on the
helix H8128,29. Structural analysis of the cryo-EM structure of
human 80S ribosome30 reveals that the Ade4220-residing
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segment adopts a stem-loop structure, with nucleotides Cyt4211-
Cyt4221 extending as a twisted loop on top of a six base pair (bp)-
long stem (Fig. 3a). To determine whether the RNA secondary
structure contributes to the substrate specificity of ZCCHC4, we
compared the methylation activity of ZCCHC4 on the 30-mer
RNA (Cyt4199-Gua4228), encompassing the stem-loop segment
as well as a 5 nucleotide (nt)-long 5′ overhang, and a 12-mer RNA
(Cyt4215-Gua4226) that was used by a previous study9, which
presumably lacks of any secondary structure (Fig. 3b).
ZCCHC4 shows a 104-fold higher activity on the 30-mer RNA
over the 12-mer RNA (Fig. 3b), suggesting that the structural
feature of the 30-mer RNA may influence the methylation effi-
ciency of ZCCHC4. Next, we aimed to disrupt the RNA stem
structure by mutating four stem nucleotides, Ura4208, Gua4225,
Gua4226, and Ura4227, into Ade4208, Cyt4225, Cyt4226, and
Ade4227, respectably. The methylation activity of ZCCHC4 shows
a 50-fold reduction on the “broken stem” RNA than on the native
28S RNA (Fig. 3b). In contrast, swapping of four complementary
bases on the stem that are either 2- or 3-bp away from the RNA
loop, only led to 1.2- and 1.5-fold reduction of the enzymatic
activity, respectively (Fig. 3b). Similarly, removal of the 5′ over-
hang or retaining a same-length 3′ overhang instead only led to a
modest decrease of the methylation activity of ZCCHC4, sug-
gesting that the stem, rather than the overhang sequence, is
essential for the substrate specificity of ZCCHC4. Together, these
observations suggest that ZCCHC4 recognizes a combined
sequence and structural feature of 28S rRNA.
Mapping of the RNA-binding surface of ZCCHC4. Structural
analysis of ZCCHC4, along with the aforementioned RNA
binding and enzymatic analyses, argues for an important role of
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the MTase-associated domains in ZCCHC4-mediated RNA
methylation. Analysis of the electrostatic surface of ZCCHC4
further reveals that the GRF domain forms a hydrophobic patch
next to the active site (Fig. 4a, b), which might serve as an
extended RNA-binding surface. In support of this notion, resi-
dues F61, R68, F76, and W78 on the GRF domain are evolutio-
narily conserved, with F61 representing one of the signature
residues in the GRF domain-defining motif (Supplementary Figs.
1, 5e). In fact, a previous study, based on NMR chemical shift
perturbation analysis, has demonstrated that the counterparts of
these residues in the GRF domain of APE2 mediate the binding of
APE2 to the single-stranded DNA26. On the opposite side of the
catalytic center, an interdomain cleft formed between the MTase
and CCHC domains presents another surface patch containing
basic and hydrophobic residues (Fig. 4a, b), which potentially also
contributes to the substrate binding of ZCCHC4.
To further analyze the RNA-binding sites of ZCCHC4, we have
selected a number of residues from these surface patches of the
GRF and CCHC domains, along with the residues surrounding
the catalytic site of the MTase domain, for mutagenesis and
enzymatic assays. Our results showed that mutation of residues
on the surface patches of the GRF and MTase domains severely
compromised the activity of ZCCHC4 (Fig. 4c). Mutations of
the residues on the surface patch in the interdomain cleft between
the MTase and CCHC4 domains also significantly reduced
the activity of ZCCHC4, albeit to a lesser extent (Fig. 4c). Note
that none of these mutations led to a substantial decrease in
RNA-binding activity of ZCCHC4 (Supplementary Fig. 8b),
highlighting the delicacy of RNA substrate binding in ZCCHC4-
mediated methylation. The mutational effects of these residues
are well in line with their sequence conservation (Supplementary
Fig. 8c), indicating their important roles in ZCCHC4-mediated
RNA methylation. In contrast, mutation of residue K419 located
further away from the MTase domain, residue Q153 on the C2H2
domain, or residue R87 on the GRF domain, did not appreciably
affect the enzymatic activity of ZCCHC4 (Fig. 4c), which sets a
boundary for the potential RNA-binding surface of ZCCHC4. It
is worth noting that, out of the five surface mutations introduced
for crystallization, sites K167 and K168 both fall into this RNA-
binding surface of ZCCHC4, consistent with the observation for a
large reduction of ZCCHC4 activity by these mutations
(Supplementary Fig. 8d, e). Together, these mutational analyses
provide a sketched view on the RNA-binding surface of
ZCCHC4, spanning from the GRF domain to the CCHC domain.
Discussion
The m6A RNA methylation is increasingly appreciated as an
important epitranscriptomic mechanism for regulation of the
metabolism, trafficking and/or function of a diverse array of RNA
molecules, which critically impacts on the behavior and pheno-
type of cells. To date, little is known about how different m6A
writer enzymes target distinct RNA substrates for carrying out
their respective roles in RNA modulation. Through structural,
biochemical, and enzymatic characterization of ZCCHC4, a
recently reported rRNA m6A writer, this study reveals the
molecular basis for the ZCCHC4-mediated m6A4220 modifica-
tion of 28S rRNA. Importantly, ZCCHC4 forms a multidomain
RNA-binding platform, permitting its specific recognition of a
stem-loop feature inherent in the 28S rRNA substrate. Further-
more, it reveals a loop segment that controls both the enzymatic
catalysis of ZCCHC4 and its SAM-binding activity, providing a
potential mechanism by which ZCCHC4 achieves substrate spe-
cificity. This study therefore illustrates a previously unappreciated
dynamic interplay between the RNA substrate and its m6A writer,
with important implication in the functional regulation of ribo-
some assembly, translation, and cell proliferation.
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Uniquely among all the m6A RNA methyltransferases identi-
fied so far, ZCCHC4 manifests an autoinhibitory conformation,
with the regulatory loop occluding the catalytic site from RNA
binding. Our structural modeling analysis, along with enzymatic
assays, demonstrated that the regulatory loop may serve as a key
element that couples RNA substrate recognition with the con-
formational state of ZCCHC4. Although the functional implica-
tion of this intramolecular regulation remains to be determined, it
is conceivable that the interaction between the regulatory loop
and the 28S rRNA leads to conformational rearrangement of
ZCCHC4, thereby switching ZCCHC4 from an inactive state to
an enzymatically active state (Fig. 4d). The other important
observation is that the SAH-binding pocket adopts a fully closed
conformation, which is in part strengthened by the intramole-
cular interaction between the regulatory loop and cofactor loop. It
is therefore likely that the RNA substrate binding-triggered
conformational change of the regulatory loop may also lead to
destabilization of this intramolecular interaction, which conse-
quently enhances the SAM-binding affinity of ZCCHC4. Toge-
ther, these intramolecular interactions of the regulatory loop
likely provide a gating mechanism for the RNA substrate and
cofactor binding of ZCCHC4, which may contribute to its sub-
strate specificity. This regulatory mechanism is reminiscent of
mammalian DNA methyltransferase 1 (DNMT1)-mediated DNA
methylation, in which an interdomain linker of DNMT1 mediates
an autoinhibitory conformation to control its substrate specifi-
city31. It is worth mentioning that an autoinhibitory conforma-
tion was also previously observed for METTL16, but likely in a
different functional context20: the RNA binding of METTL16
triggers a conformational re-organization of the SAM-binding
pocket (Supplementary Fig. 8 f), which in turn reduces the
activity of METTL1620. Likewise, binding of SAM or SAH to
METTL3 also induces a conformational change of a loop segment
at the cofactor-binding site, namely gate loop, resulting in
binding-induced folding of the SAM-binding pocket (Supple-
mentary Fig. 8g)13,14. These observations suggest that cofactor
binding-coupled conformational changes may represent a com-
mon mechanism for various m6A writers.
Previous studies have demonstrated that ZCCHC4 shows high
specificity toward 28S rRNA: it specifically methylates Ade4220 of
28S rRNA, but not Ade1832 of 18S rRNA, the other methylation
site of rRNA, even though both sites are embedded in an AAC
motif9. Through nucleotide complementation analysis, this study
demonstrates that the stem-loop structure critically influences the
methylation activity of ZCCHC4. In this regard, structural ana-
lysis of 18S rRNA reveals a discrete structural environment for
Y318 D276
F319
N342
Y340
H343
K419
F61
F76
F48
R68
K403
H436W 08
K416
Y173
W78
R323
R87
Q153
MTase
CCHC
GRF
C2H2
a b
c d
GRF
CCHC
C2H2
28S rRNA
Autoinhibitory
Active
C2H2-
MTase
C2H2-
MTase
CCHC
CCHC
GRF
GRF
A
GRF
MTase
CCHC
n.s. n.s.
n.s.
1.5
0
0.5
1.0
R
el
at
iv
e 
ac
tiv
ity
WT F4
8A
F6
1A
R6
8A
F7
6A
W7
8A
D2
76
A
Y3
18
A
F3
19
A
R3
23
A
K4
03
A
W4
08
A
K4
19
A
K4
16
A
R8
7A
Q1
53A
Y1
73
A
C2H2
Fig. 4 Mapping of the substrate-recognition surface of ZCCHC4. a Electrostatic surface of ZCCHC424-464, with the potential RNA-binding surface marked
by dashed circle. b The mutational sites associated with the activity loss of ZCCHC4 are shown in stick representation and color-coded in the same fashion
as the corresponding domains. The residues whose mutations failed to affect ZCCHC4 activity appreciably are shown as gray sticks. c Relative methylation
activity of selected ZCCHC424-513 mutants over WT. The data are mean ± SD. Statistical analysis used two-tailed Student’s t test for the difference from
WT: n.s., not significant; ***p < 0.001. Source data are provided as a Source Data file. d Model for the substrate recognition of ZCCHC4. The regulatory
loop (blue) occludes the active site (red star) in RNA-free state. In the presence of the cognate substrate 28S rRNA, the regulatory loop readjusts
conformation for RNA interaction, leading to the active state of ZCCHC4
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12923-x ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:5042 | https://doi.org/10.1038/s41467-019-12923-x | www.nature.com/naturecommunications 7
site 1832, which forms a base pair with Cyt1732 at the base of
helix 44 (Supplementary Fig. 8h), providing an explanation for
the lack of methylation activity of ZCCHC4 on this site. Through
nucleotide replacement analysis, this study suggests that the stem-
loop structural feature of 28S rRNA significantly contributes to
the substrate specificity of ZCCHC4. Future investigation is
warranted to further determine whether or not the stem region of
the RNA substrate directly engages ZCCHC4 interaction or
functions to stabilize the conformation of the RNA loop.
Lastly, this study has demonstrated how various structural
modules within ZCCHC4 act in synergy for mediating the
binding and methylation of substrates. In particular, the GRF and
CCHC modules, through direct association with the MTase
domain, extend the substrate-binding surface, permitting a rather
large RNA-binding platform to accommodate the substrate spe-
cificity. In fact, all the RNA m6A methyltransferases identified so
far, except for METTL5, contain MTase-flanking domains, sug-
gesting a flanking-module-directed regulation, as we herein show
for ZCCHC4, as a widely adopted mechanism for m6A writers,
ensuring both binding affinity and substrate specificity. For
instance, METTL3 harbors an N-terminal CCCH zinc finger
domain that specifically recognizes the RNA substrate containing
the GGACU motif32, which is essential for the methylation
activity of the METTL3–METTL14 complex14,32. The detailed
mechanism by which the MTase-associated domains of ZCCHC4
regulate its activity awaits further investigation.
Methods
Protein expression and purification. DNAs encoding human ZCCHC4, full-
length or various fragments (ZCCHC424-513: residues 24-513; ZCCHC424-464:
residues 24–464; ΔCCHC: residues 24–368; ΔGRF: residues 100–464; ΔGRF-C2H2:
residues 159–464) were each inserted into a modified pRSF-Duet vector, preceded
by an N-terminal hexahistidine (His6)-SUMO tag and a ubiquitin-like protease 1
(ULP1) cleavage site. To promote crystallization, five surface mutations (K55A,
E56A, E57A, K167A, and K168A) were introduced onto the ZCCHC424-464 con-
struct, which presumably would lead to surface entropy reduction. On the other
hand, for biochemical and enzymatic characterizations, various point mutations
were generated based on the wild-type ZCCHC424-513 construct. For protein
expression, BL21(DE3) RIL cells harboring the expression plasmids were induced
by addition of 0.4 mM isopropyl-β-D-thiogalactoside (IPTG) when the cell density
reached optical density at 600 nm (A600) of 0.8, and continued to grow at 15 °C
overnight. The cells were harvested and lysed in buffer containing 50 mM Tris–HCl
(pH 8.0), 1 M NaCl, and 25 mM imidazole, 10% glycerol, 10 µg/mL DNase I, 10 µg/
mL RNase A, and 1 mM PMSF. Subsequently, the fusion proteins were purified
through a nickel column, followed by removal of His6-SUMO tag by ULP1 clea-
vage, ion-exchange chromatography and size-exclusion chromatography. The
purified protein samples were concentrated in 20 mM Tris–HCl (pH 7.5), 100 mM
NaCl, 5% glycerol, and 5 mM DTT, and stored at −80 °C freezer before use.
Crystallization and structure determination. For crystallization of the
ZCCHC4–SAH complex, 10 mg/mL ZCCHC4 was mixed with SAH in a molar
ratio of 1:5, before incubation with 0.03 M citric acid, 0.07M Bis–Tris propane (pH
7.6), 11–12% PEG3350, 10% glycerol, and 5 mM TCEP (Tris (2-carboxyethyl)
phosphine hydrochloride) (pH 7.0) using the sitting drop vapor-diffusion method
at 12 °C. For crystal harvesting, the crystals were soaked in the well solution
supplemented with 20% (v/v) ethylene glycol before flash frozen in liquid nitrogen.
X-ray diffraction data were collected on beamline 5.0.2 at the Advanced Light
Source (ALS), Lawrence Berkeley National Laboratory with a wavelength of 1.283
Å and processed with the HKL3000 program33. Experimental phasing and initial
model building was carried out by the Zn-SAD method using the CRANK2 pro-
gram34. Subsequently, iterative cycles of model building and refinement were
carried out using COOT35 and PHENIX36, respectively. The statistics for data
processing and structure refinement are summarized in Supplementary Table 1.
Electrophoretic mobility shift assay. To measure the binding between ZCCHC4
and the 30-mer 28S rRNA (5′-CGGUACA CCUGUCAAACGGUAACGCAG
GUG-3′), unless indicated otherwise, 0.3 μM RNA was incubated with 0, 0.3, 0.6, or
1.2 μM ZCCHC424-513 in buffer containing 20 mM Tris–HCl (pH 7.5), 100 mM
NaCl, 5% glycerol, 1 mM DTT at 4 °C for 1 h. Five μL of the mixture was loaded
and resolved in 6% TBE native gel at 4 °C under 100 V for 0.5 h. The gel image was
visualized by SYBR Gold (Thermo Fisher) staining and subsequently by Coomassie
blue staining.
RNA methylation kinetics assay. The RNA methylation assays follow a pre-
viously published protocol (Song et al.31) with modifications. Each reaction mix-
ture contains 25 nM ZCCHC424-513, wild-type or mutants, 0.5 μM S-adenosyl-L-
[3H] methionine (Perkin Elmer) and 1 μM RNA substrate in 50 mM Tris–HCl (pH
8.0), 7 mM β-ME, 5% glycerol, 100 μg/mL BSA, and 10 μM zinc acetate. The
reaction mixture was incubated at 37 °C for 15–20 min, before quenched by 2 mM
cold SAM. Ten μL of the reaction mixture was applied onto DEAE filtermat
(Perkin Elmer), sequentially washed with 0.2 M ammonium bicarbonate (pH 8.2)
twice, water once, and ethanol once. The filter paper was then air dried and soaked
in ScintiVerse cocktail (Thermo fisher). The activity was measured by Beckman
LS6500 scintillation counter. All the experiments were performed in three biolo-
gical replicates and repeated with consistent results.
ITC measurements. ITC measurements were performed using a MicroCal iTC200
instrument (GE Healthcare). To measure the bindings between the ZCCHC424-513,
WT or H343A mutant, and SAM, 0.1 mM ZCCHC424-513 protein sample was
dialyzed against buffer (20 mM Tris–HCl (pH 7.5), 100 mM NaCl, 1 mM TCEP)
overnight. 1 mM SAM compound (Sigma) was dissolved in the same buffer.
Titration of SAM in the syringe over ZCCHC424-513 samples was carried out at
5 °C. The time between each injection was set at 180 s. All data were processed with
the MicroCal Origin software and fitted with the single-site binding mode. The Kd
values and error estimates were derived from the duplicated experiments.
NMR experiments. For 1H NMR experiments, 0.05 mM purified mutant ZCCHC4
proteins were dissolved in 250 μL buffer containing 50 mM sodium phosphate (pH
6.7), 1–3 mM Tris–HCl, 150 mM NaCl, and 10% D2O. NMR spectra were collected
on a Bruker Advance 700MHz NMR spectrometer equipped with a TXI probe at
25 °C and processed using the Bruker TopSpin software.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Coordinates and structure factors for ZCCHC4–SAH complex have been deposited in
the Protein Data Bank under accession code 6UCA. The PDB accession codes 4UG0,
5K7M, 5K7W, 5L6D, 5IL2, 6IRY, 6DU4, 6B92, 6BML, and 6H2U were used in this study.
All other data are available from the corresponding authors upon reasonable request. The
source data underlying Figs. 1e, 2d, g, 3b, and 4c, and Supplementary Figs. 5g and 8a, b, e
are provided as a Source Data file.
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